- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01968525
The Effect of Chronic Anemia on Safety Period of Tracheal Intubation in Gynecology Patients
October 18, 2013 updated by: Geng guiqi, Fudan University
- Every individual receiving a general anesthetic is at potential risk for developing a ''cannot intubate-cannot ventilate'' situation following anesthetic induction.
- Building up of oxygen reserves assumes great significance as this provides a longer duration of non-hypoxic apnea should one be faced with an unanticipated difficult airway.
- The main physiological functions of red blood cell hemoglobin are to deliver oxygen to the peripheral tissues.
- During anemia, a reduction in blood oxygen content occurs as a result of reduced Hb while arterial oxygenation and oxyhemoglobin saturation remain high.
- Previous studies about the duration of non-hypoxic apnoea focus on methods to improve the safety period of tracheal intubation.
- To our knowledge, there is no literature about the duration of non-hypoxic apnoea of anemia patients.
- The aim of this study was to assess the effect of chronic anemia on the duration of non-hypoxic apnoea during induction of anaesthesia.
Study Overview
Detailed Description
After breathing for 3 minutes, anesthesia induction was conducted.
The endotracheal tube position was confirmed after anesthesia induction.
Patients were left apneic with the endotracheal tube open to room air.
The non-hypoxic apneic period was recorded as the time (in seconds) taken for the drop in pulse saturation to 90% or an apneic period of 10 min elapsed, whichever was earlier.
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200090
- Fudan University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- patients scheduled to undergo general anesthesia
- American Society of Anesthesiologists Performance Status 1-2
- adults
Exclusion Criteria:
- Individuals with significant cardiorespiratory or cerebrovascular disease,
- difficult intubation
- history of epilepsy
- body mass index >25 kg/m2,
- and those who had smoking history in past 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group A
the hemoglobin is >12g/L in patients from group A.
|
3 min of preoxygenation before anesthesia induction.
|
Experimental: Group B
Hb 9-12g/L
|
3 min of preoxygenation before anesthesia induction.
|
Experimental: Group C
Hb<9g/L
|
3 min of preoxygenation before anesthesia induction.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
duration of non-hypoxic apnoea
Time Frame: up to 6 months
|
up to 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Guiqi Geng, PhD, Department of anesthesiology, obstetrics and genecology hospital, FuDan university
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2013
Primary Completion (Actual)
September 1, 2013
Study Completion (Actual)
September 1, 2013
Study Registration Dates
First Submitted
October 12, 2013
First Submitted That Met QC Criteria
October 18, 2013
First Posted (Estimate)
October 24, 2013
Study Record Updates
Last Update Posted (Estimate)
October 24, 2013
Last Update Submitted That Met QC Criteria
October 18, 2013
Last Verified
October 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 199987
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Anemia
-
Helwan UniversityCompletedAnemia of Chronic Kidney Disease | Chronic Renal Failure | Chronic Renal Failure AnemiaEgypt
-
Kumamoto UniversityCompletedHemodialysis | Iron Deficiency Anemia | Chronic Renal Failure | Renal AnemiaJapan
-
Iuliu Hatieganu University of Medicine and PharmacyUnknownAnemia, Iron Deficiency | Anemia of Chronic DiseaseRomania
-
Keryx BiopharmaceuticalsCompletedAnemia of Chronic Kidney DiseaseIsrael
-
Hoffmann-La RocheCompletedChronic Renal AnemiaGreece
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Autoimmune Hemolytic Anemia | Warm Antibody Autoimmune Hemolytic Anemia | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Universidade Federal FluminenseActive, not recruitingDysbiosis | Anemia of Chronic Kidney Disease | Chronic Renal Disease | Iron-Deficiency AnemiaBrazil
-
AMAG Pharmaceuticals, Inc.CompletedIron Deficiency Anemia Treatment | Chronic Kidney Disease(CKD)United States, Canada, United Kingdom
-
National Cancer Institute (NCI)CompletedAdult Acute Myeloid Leukemia in Remission | Accelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Previously Treated Myelodysplastic Syndromes | Relapsing Chronic Myelogenous Leukemia | Refractory Anemia With Excess Blasts | Refractory Anemia With Excess...United States
-
Unity Health TorontoTerminatedAnemia, Iron Deficiency | Knee Arthropathy | Hip Arthropathy | Anemia of Chronic DiseaseCanada
Clinical Trials on pre-oxygen
-
Ullevaal University HospitalCompleted
-
University Health Network, TorontoU.S. Army Medical Research and Development Command; Princess Margaret Hospital...Active, not recruiting
-
University Health Network, TorontoCanadian Cancer Trials Group; Princess Margaret Hospital, CanadaActive, not recruiting
-
Karolinska University HospitalUniversity College London Hospitals; St. George's Hospital, London; Poole Hospital...CompletedHypoxia | Surgery | Anesthesia | AcuteSweden, Switzerland
-
National Baromedical ServicesMayo Clinic; Dartmouth-Hitchcock Medical Center; Eastern Virginia Medical School and other collaboratorsCompletedCarcinoma, Squamous Cell | Cancer of the Head and NeckUnited States
-
SRI InternationalCompleted
-
Aalborg University HospitalRigshospitalet, Denmark; Copenhagen Trial Unit, Center for Clinical Intervention...Active, not recruitingHypoxemic Respiratory Failure | Oxygen ToxicityNorway, Switzerland, Denmark
-
Aalborg University HospitalUniversity of AarhusUnknownCardiac Surgery | Cardiopulmonary Bypass | Acute Lung Injury | Hyperoxia | Oxygen ToxicityDenmark
-
Chang, Steve S., M.D.Santa Barbara Cottage HospitalCompletedPostoperative AbscessUnited States
-
Royal Brompton & Harefield NHS Foundation TrustLiverpool University Hospitals NHS Foundation Trust; National Institute for...CompletedLung; Disease, Fibroid (Chronic)United Kingdom